retatrutide and test How Long Does Take to Work? Retatrutide | Research Grade Peptide
Description
The GIP receptor activation appears to reduce nausea compared to pure GLP-1 agonists, which is why retatrutide shows a 28% nausea rate versus 44% for semaglutide despite being more potent
Persistent Symptoms If you have been on the same dose for over a month and the nausea is not improving, it is time to talk to your provider
Messineo L et al
Patients consistently report significant improvements in cardiovascular health, with reduced blood pressure, improved cholesterol profiles, and enhanced heart function
